I think the new choice of CEO is important, and hopefully we hear something about that relatively soon. Personally, I would choose someone who is focused on the operations, and the processes we need to tidy up our trials and deliver results. Frankly, it would be someone a lot like Chris Recknor, who is soft spoken but under promises and over delivers.

Someone like that, could finally give us the legitimacy and respect in the pharma community, the FDA, etc. Some on here would rather say “screw the FDA“, but at the end of the day, we do not want to be at war with our regulatory bodies here in the US. It’s just not smart.

I’m hopeful that this new path forward will finally marry a world class drug, with a professional leadership team that goes about their business and starts knocking out one approval after the other.. Thismight be the final piece of the puzzle we need to take this to the next level.